Data from the phase 3 ENVISION trial demonstrate the potential of UGN-102 as an effective and durable nonsurgical treatment for patients with low-grade, intermediate-risk non–muscle-invasive bladder cancer.
Breelyn Wilky, MD, discusses the importance of disease screening and early diagnosis in the treatment of patients with sarcoma.
The addition of pembrolizumab to preoperative radiation therapy followed by surgery prolonged DFS in patients with soft tissue sarcoma of the extremity.
More than 2 million new cases of cancer will be diagnosed in the US this year, and more than 600,000 people will die of cancer,…
Early palliative care reduces invasive interventions and enhances comfort at EOL for CRC patients, according to real-world study results.
Here is your snapshot of all therapeutic options that were approved by the FDA in January 2025 spanning tumor types.
An abstract is unavailable.
Despite focused efforts to improve the diversity of clinical trials, representation in research into head and neck cancer has become less equitable over the past…
Lumps and bumps are often early signs of breast cancer. These pictures of breast cancer bumps show you what to look for to determine if…
A panelist discusses how CAR-T cell therapy patient selection involves evaluating disease characteristics like relapse/refractory status and tumor burden, patient-specific factors including performance status and…
The FDA granted RMAT designation to gemogenovatucel-T for maintenance treatment after frontline chemotherapy in advanced HRP ovarian cancer.
